Why Do Cheeks Become Bumpy Months After AestheFill?

"My cheeks were smooth for the first few months after AestheFill. Then lumps started appearing, and three rounds of 5-FU didn't fix them." At FILLER REVISION, AestheFill complications have become one of our fastest-growing consultation categories. Patients arrive after multiple failed rounds of pharmacological treatment, often surprised to learn that their PDLLA nodules require a fundamentally different approach than medication alone.

However, a significant number of patients find that three to six months after injection, the anticipated "natural plumpness" transforms into uneven cheek contours, palpable hard lumps, or even visible subcutaneous nodules. The shift from anticipation to distress leaves many patients feeling helpless.

Key Insight: At FILLER REVISION, we see this pattern regularly — although AestheFill (PDLLA) and Sculptra (PLLA) share similar chemistry, their microsphere morphology and degradation kinetics differ, and these differences influence the pattern and severity of complications. This distinction matters for treatment planning.

Understanding AestheFill: Composition, Mechanism, and Risks

PDLLA Microsphere Characteristics

The core component of AestheFill is PDLLA microspheres. Unlike the pure L-form PLLA in Sculptra, PDLLA is a copolymer of both D- and L-lactic acid:

Property | AestheFill (PDLLA) | Sculptra (PLLA)

---------- | ------------------- | -----------------

Chemistry | Poly-D,L-lactic acid | Poly-L-lactic acid

Crystallinity | Amorphous | Semi-crystalline

Degradation rate | Theoretically faster | Theoretically slower

Microsphere shape | Porous spheres | Irregular fragments

Collagen stimulation | Porous structure promotes cell ingrowth | Surface stimulates collagen formation

Why Uneven Texture Develops

The causes of post-AestheFill texture irregularity are multifactorial:

Technical Factors

- Insufficient dilution: High microsphere concentration promotes aggregation

- Uneven injection depth: Variable placement creates non-uniform collagen stimulation

- Inconsistent injection speed: Some areas receive disproportionately dense deposits

Biological Factors

- Individual collagen response varies significantly between patients

- Local blood circulation affects degradation rate

- Tissue tension differences lead to variable collagen growth patterns

Microsphere-Related Factors

- Porous structure may provoke localized intense fibrosis

- Microsphere aggregation forms "cores" that become excessively wrapped in collagen

- Non-uniform degradation creates areas of persistent stimulation

Key Insight: Texture irregularity typically becomes apparent 2–6 months post-injection, coinciding with peak collagen production. The window between "looking great" and "growing concerned" can be alarmingly short.

Conventional Treatments and Their Limitations

5-FU (5-Fluorouracil) Injection

5-FU is an antimetabolite medication sometimes used to treat collagen stimulator nodules. It works by inhibiting fibroblast proliferation and reducing excessive collagen formation.

Aspect | Details

-------- | ---------

Mechanism | Inhibits fibroblast DNA synthesis

Best suited for | Early inflammatory nodules

Frequency | Every 2–4 weeks

Typical course | 3–5 sessions

Limitation | Limited effect on mature fibrous capsules

Steroid Injection

Intralesional steroid injection (triamcinolone) is also commonly attempted to soften nodules:

Potential Benefit | Risk

------------------ | ------

Anti-inflammatory effect | Skin atrophy

Temporary softening | Hypopigmentation

Pain reduction | Telangiectasia

— | Fat atrophy (especially noticeable on the face)

When 5-FU and Steroids Fail

Clinical experience shows that 5-FU and steroids have limited effectiveness in the following scenarios:

Mature encapsulated lumps: Drugs cannot penetrate the fibrous barrier

Heavily aggregated microsphere nodules: Medication reduces surrounding inflammation but the core material remains

Multiple deep nodules: Superficial drug injections cannot reach deep lesions

Nodules older than 6 months: Fibrosis has stabilized; drug efficacy diminishes

When 5-FU and Steroids Reach Their Ceiling: The FILLER REVISION Approach

At FILLER REVISION, the majority of AestheFill patients we treat have already completed three or more rounds of 5-FU or steroid injections without adequate resolution. The reason these treatments plateau is that AestheFill's porous PDLLA microspheres become surrounded by dense fibrous capsules that medication cannot penetrate. Additionally, the aggregated microsphere clusters form structural nodules that no anti-inflammatory or antimetabolite drug can dissolve. Our approach shifts from pharmacological suppression to physical removal: ultrasound-guided pinhole extraction that directly accesses and removes the aggregated microspheres and their fibrous capsules. This achieves in one session what continued medication rounds cannot, while avoiding the cumulative tissue damage from repeated steroid exposure.

Ultrasound-Guided Extraction: When Medical Treatment Reaches Its Limit

AestheFill Nodules on Ultrasound

AestheFill nodules display characteristic features on ultrasound imaging:

Ultrasound Feature | Clinical Significance

------------------- | ----------------------

Well-defined hypoechoic nodule | Indicates capsule formation

Hyperechoic dots within the nodule | Residual PDLLA microspheres

Altered echogenicity of surrounding tissue | Reflects local fibrosis degree

Distance between nodule and skin surface | Determines whether surface irregularity is visible

Indications for Extraction

Ultrasound-guided minimally invasive extraction should be considered when:

Three or more 5-FU sessions have produced no significant improvement

Steroid injections have caused skin atrophy while the lump persists

Nodules have been present for over 6 months and affect appearance

The patient cannot accept waiting 2–3 years for natural degradation

Superficial nodules are severely disrupting facial contour

The Extraction Process

Assessment Phase

Detailed history: AestheFill batch, injection date, treatment areas, and dosage

Ultrasound scan: Document all nodule locations, dimensions, depth, and capsule characteristics

Discuss realistic expectations with the patient

Surgical Phase

Local anesthesia

1–2mm pinhole incision

Real-time ultrasound-guided approach to the nodule

Fragment the capsule and extract aggregated PDLLA microspheres

Ultrasound confirmation of extraction completeness

Post-Procedure Phase

Light compression for 24–48 hours

One-week follow-up

Ultrasound monitoring at 1 month and 3 months

Expected Results

Nodule Type | Single-Session Expectation

------------- | ---------------------------

Single superficial nodule | >90% improvement

Multiple superficial nodules | Can treat several simultaneously

Deep nodules | Good improvement; may require pathway confirmation

Diffuse texture irregularity | Noticeable improvement; may need staged treatment

Preventing AestheFill Complications

Pre-Injection Evaluation

Understand your skin thickness and tissue conditions

Confirm the practitioner's experience with AestheFill specifically

Discuss injection volume (less is more)

Establish a plan for managing complications if they arise

The Importance of Injection Technique

Best Practice | Risk Practice

--------------- | --------------

Adequate dilution | Insufficient dilution

Deep, uniform injection | Variable depth placement

Small volumes over multiple sessions | Large single-session volumes

Post-injection massage for even distribution | Neglecting post-injection massage

Avoiding thin-skinned periorbital area | Injecting in high-risk zones

Do Not Let Texture Irregularity Become a Long-Term Burden

If you've already tried treatment for AestheFill lumps or uneven texture without success, FILLER REVISION specializes in exactly these cases. Our ultrasound-guided extraction provides the definitive solution when 5-FU and steroids have reached their limits.

About the Author

Dr. Liu Ta-Ju

Current Position: Director, Liusmed Clinic

Specialties: Minimally invasive surgery, filler complication repair, ultrasound-guided extraction

Experience: 15+ years of clinical minimally invasive surgery; over 10,000 successful cases

Philosophy: "Managing collagen stimulator complications requires patience and precision. Medical treatment has its role, but when medication reaches its limit, minimally invasive extraction provides the definitive answer."